Prescribe the continuous glucose monitoring (CGM) system that’s more
affordable†1 for your patients.
The FreeStyle Libre 2 system is now widely covered by Medicare for patients
managing diabetes with insulin‡2.
Write a standard prescription for either system:
Commercially insured and cash-pay patients can fill their Rx at participating pharmacies¶ with their choice of either the
FreeStyle Libre 2 or FreeStyle Libre 3 systems.
The FreeStyle Libre apps, sensors, and readers cannot be used interchangeably across the family of products.
If your commercially insured patients are asked to pay >$75 for two sensors or have questions about
coverage and costs, please have patients call 844-330-5535.
Medicare patients managing diabetes with insulin are now eligible for coverage for the FreeStyle Libre 2 system‡2.
To be eligible for Medicare coverage, the prescription must include both the reader and sensors, and the reader must be used on some days every month. At this time, the FreeStyle Libre 3 system is not eligible for Medicare reimbursement††.
For questions regarding Medicare Fee-for-Service coverage, please visit www.medicare.gov.
For Medicaid patients, use this grid to contact a DME supplier who carries the FreeStyle Libre 2 system.
Have your patient download the corresponding FreeStyle Libre 3 app§ or FreeStyle Libre 2 appǁ
and check to see if their smartphone is compatible§ǁ.
Smartphone app§
Smartphone appǁ
FreeStyle Libre 2 reader
For patients without a compatible smartphoneǁ. The FreeStyle Libre 2 reader‡‡ is only compatible with the FreeStyle Libre 2 sensor. No standalone reader is available for the FreeStyle Libre 3 system.
Onboarding
An introduction to CGM basics to support a solid onboarding experience for patients.
Activity
Daily activities so patients can learn how food and activity impacts their glucose levels.
Interactive check-ins
Tools where patients can
personalize their own
learning path.
Resources
Easy access to
video tutorials.
Questions? Contact our Customer Care Team at 855-632-8658 7 days a week from 8AM to 8PM EST, excluding holidays.
Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
At this time, FreeStyle Libre 3 is not currently eligible for Medicare reimbursement, and Medicaid eligibility may vary by state.
Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
* No prior authorization needed at participating pharmacies. This applies to commercially insured patients. This does not apply to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. Participating pharmacies are subject to change without notice.
† Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
‡ Patients must meet Medicare eligibility coverage criteria.
§ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app.
ǁ The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.
¶ Participating pharmacies are subject to change without notice. Product availability may vary by retailer.
# Patients must meet Medicare eligibility coverage criteria: Local Coverage Determination, Glucose Monitors (L33822) February 2022.
** DMEs are subject to change without notice.
†† Medicare coverage is available for the FreeStyle Libre 2 system if a smartphone with the FreeStyle Libre 2 app is used in conjunction with the FreeStyle Libre 2 reader to review glucose data. Medicare coverage is not available if a patient never uses the FreeStyle Libre 2 reader, and patients must meet other applicable coverage criteria.
‡‡ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
References: 1. Data on File. Abbott Diabetes Care. 2. Local Coverage Determination (LCD) L33822, Glucose Monitors, https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822.
ADC-42706 v3.0 04/23
Important Safety Information
FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre 2 or FreeStyle Libre 3 systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre Pro: The FreeStyle Libre Pro Flash Glucose Monitoring System is a professional continuous glucose monitoring (CGM) device indicated for detecting trends and tracking patterns and glucose level excursions above or below the desired range, facilitating therapy adjustments in persons (age 18 and older) with diabetes. The system is intended for use by health care professionals and requires a prescription.
IMPORTANT: The device may inaccurately indicate hypoglycemia. The results of the clinical study conducted for this device showed that 40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81-160 mg/dL. Therefore, interpretation of the FreeStyle Libre Pro Flash Glucose Monitoring System readings should only be based on the trends and patterns analyzed through time using the reports available per the intended use.
CONTRAINDICATIONS: Remove the Sensor before MRI, CT scan, X-ray, or diathermy treatment.
WARNINGS/LIMITATIONS: The FreeStyle Libre Pro System does not provide real-time results and patients should adhere to their blood glucose monitoring routine while using the system. If a sensor breaks, contact physician and call Customer Service. Patients with high levels of ascorbic acid (Vitamin C) or salicylic acid (used in Aspirin) or severe dehydration or excessive water loss may experience inaccurate results with this system. The FreeStyle Libre Pro System is not approved for pregnant women, persons on dialysis, or recommended for critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. Review all product information before use or contact Abbott Toll Free (855-632-5297) (or visit provider.myfreestyle.com) for detailed indications for use and safety information.
The product images are for illustrative purposes only.
The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v12.0 04/23
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
